八月 2026
- Home
- Lovelace Biomedical
八月 2026的Lovelace Biomedical市场份额分析
Lovelace Biomedical’s expansive campus enables us to carry out sensitive projects in Albuquerque, New Mexico. Learn more here.
Lovelace Biomedical(包含公司地区分支机构)
查看更多网站流量和参与度信息- lovelacebiomedical.org
Lovelace Biomedical收入截至 八月 2026为 100M - 200M
Lovelace Biomedical主要域名产生的收入
3 年中Lovelace Biomedical主要域名的收入
Lovelace Biomedical主要域名的收入
Lovelace Biomedical热门域名的总访问量
了解Lovelace Biomedical市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Lovelace Biomedical热门域名的平均访问时长
分析Lovelace Biomedical参与度指标。
过去 3 个月的平均访问时长
子公司明细
Lovelace Biomedical热门域名的平均页面浏览量
了解Lovelace Biomedical如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Lovelace Biomedical 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Toma left Lovelace Biomedical as Executive Vice President, Chief Operating Officer, and Chief Financial Officer on Jun 29th '26.Toma joins MRIGlobal from Lovelace Biomedical Research Institute, where she served as Executive Vice President, Chief Operating Officer, and Chief Financial Officer.
六月 29, 2026阅读更多
新闻Lovelace Biomedical hired Andrew Alexander as Senior Director of Preclinical Toxicology on Jan 1st '26.[Albuquerque, N.M. - 2/5/2026] - Lovelace Biomedical, a not-for-profit preclinical contract research organization (CRO) that helps pharma, biotech, and federal partners generate the early-stage data required to advance therapies toward clinical testing, has appointed Andrew Alexander, DVM, PhD, MBA, DABT, Senior Director of Preclinical Toxicology.
二月 6, 2026阅读更多
新闻New York Medical College partnered with Lovelace Biomedical on Jul 6th '22.To further enhance their research capabilities, NYMC, a member of TU, formed an affiliation with Lovelace last year.
七月 5, 2023阅读更多
查看 Lovelace Biomedical 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
